Search Results 71-80 of 13713 for Birmingham

  1. A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis - Mayo Clinic

    The key outcomes in the study focus on evaluation of clinical remission, defined as Birmingham Vasculitis Activity Score (BVAS)=0 with a corticosteroid dose ...

  2. Publications - Corrie R. Bach, M.D. - Mayo Clinic

    ... Birmingham Histiocytosis Working Group. Clinical features and outcomes in primary nervous system histiocytic neoplasms. Blood Cancer J 2024 Jun 20; 14 (1): ...

  3. Thomas F. Bergquist, Ph.D., L.P. - Mayo Clinic Faculty Profiles

    ... Birmingham; Internship - Department of Psychiatry and Behavioral Sciences - APA Accredited University of Oklahoma Health Sciences Center; MA - Medical ...

  4. Donald D. Hensrud, M.D., M.S. - Mayo Clinic Faculty Profiles

    MS - Nutrition Sciences University of Alabama at Birmingham; Fellow - Clinical Nutrition University of Alabama at Birmingham; MPH - Master of Public Health in ...

  5. Babies born in rural settings are more likely to experience trauma during birth, and one way Mayo Clinic is addressing this

    D.; and Farouk Smith all of the University of North Florida, Jacksonville; and Aurora Tafili, University of Alabama at Birmingham; used Florida hospitals' ...

  6. Diseases and Conditions that Start with A - Mayo Clinic

    Browse a comprehensive list of medical diseases and conditions that start with the letter A from the experts at Mayo Clinic.

  7. Movement disorders - Doctors and departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...

  8. Alumni

    Medical school: University of Alabama School of Medicine, 2001. • Graduate class of 2004. • Location of employment: University of Alabama at Birmingham, ...

  9. Publications - Matthew J. Koster, M.D. - Mayo Clinic

    ... Birmingham Histiocytosis Working Group. Efficacy of MEK inhibitors in Erdheim-Chester disease: impact of MAPK pathway pathogenic variants. Leukemia. 2025 ...

  10. Erik H. Middlebrooks, M.D. - Mayo Clinic Faculty Profiles

    BS - Chemistry, Cum Laude University of Alabama at Birmingham. src="/-/media/kcms/gbs/research/images/. Clinical Studies. Learn about clinical trials that ...